INDRAYANI BIOTECH Financial Statement Analysis
|
||
|
The Revenues of INDRAYANI BIOTECH have increased by 2.02% YoY .
The Earnings Per Share (EPS) of INDRAYANI BIOTECH has decreased by Negative YoY. |
||
| REVENUES |
| OPERATING MARGIN |
| PROFIT AFTER TAX |
| EPS |
| ROCE |
INDRAYANI BIOTECH Last 5 Annual Financial Results
[BOM: 526445]
| Consolidated | Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 |
|---|---|---|---|---|---|
| Revenues | ₹166 Cr | ₹163 Cr | ₹62 Cr | ₹21 Cr | ₹4,989,689 Cr |
| Expenses | ₹143 Cr | ₹146 Cr | ₹55 Cr | ₹26 Cr | ₹4,712,026 Cr |
| Operating Profit (Excl OI) | ₹24 Cr | ₹17 Cr | ₹6.78 Cr | ₹-4.94 Cr | ₹277,663 Cr |
| Other Income | ₹1.22 Cr | ₹4.49 Cr | ₹0.22 Cr | ₹0.27 Cr | ₹19,704 Cr |
| Interest | ₹10 Cr | ₹5.64 Cr | ₹1.89 Cr | ₹1.97 Cr | ₹115,188 Cr |
| Depreciation | ₹3.80 Cr | ₹3.35 Cr | ₹0.66 Cr | ₹0.46 Cr | ₹101,444 Cr |
| Profit Before Tax | ₹11 Cr | ₹12 Cr | ₹4.44 Cr | ₹-11 Cr | ₹80,734 Cr |
| Profit After Tax | ₹10 Cr | ₹12 Cr | ₹4.44 Cr | ₹-11 Cr | ₹80,734 Cr |
| Consolidated Net Profit | ₹6.37 Cr | ₹8.74 Cr | ₹4.44 Cr | ₹-11 Cr | ₹80,734 Cr |
| Earnings Per Share (Rs) | ₹-0.34 | ₹1.40 | ₹2.55 | ₹1.30 | ₹-3.25 |
| PAT Margin (%) | -4.69 | 6.27 | 7.32 | 7.21 | -53.18 |
| ROE(%) | -9.25 | 19.41 | 34.86 | 20.23 | -112.29 |
| ROCE(%) | 3.19 | 14.40 | 22.45 | 16.38 | -23.16 |
| Total Debt/Equity(x) | 1.99 | 1.71 | 1.17 | 0.74 | 0.79 |
Key Financials |
||
| Market Cap | : | ₹ 66.2 Cr |
| Revenue (TTM) | : | ₹ 127.8 Cr |
| Net Profit(TTM) | : | ₹ -6.8 Cr |
| EPS (TTM) | : | ₹ -1.5 |
| P/E (TTM) | : | - |
| Industry Peers & Returns | 1W | 1M | 1Y |
| INDRAYANI BIOTECH | 3.1% | -6% | -64.6% |
| No other companies found in this Industry | |||
INDRAYANI BIOTECH Revenues
[BOM: 526445]
| Y-o-Y | 2.02 % |
| 5 Yr CAGR | -92.40 % |
| Years | Revenues | % Change | |
|---|---|---|---|
| Mar2025 | ₹166 Cr | 2.02 | |
| Mar2024 | ₹163 Cr | 164.61 | |
| Mar2023 | ₹62 Cr | 191.98 | |
| Mar2022 | ₹21 Cr | -100.00 | |
| Mar2021 | ₹4,989,689 Cr | - | |
INDRAYANI BIOTECH Operating Profit
[BOM: 526445]
| Y-o-Y | 36.67 % |
| 5 Yr CAGR | -90.39 % |
| Years | Operating Profit | % Change | |
|---|---|---|---|
| Mar2025 | ₹24 Cr | 36.67 | |
| Mar2024 | ₹17 Cr | 155.26 | |
| Mar2023 | ₹6.78 Cr | Positive | |
| Mar2022 | ₹-4.94 Cr | Negative | |
| Mar2021 | ₹277,663 Cr | - | |
| Operating Margins | |
|---|---|
| Y-o-Y | 33.99 % |
| 5 Yr CAGR | 26.48 % |
| Years | Operating Margin% | % Change | |
|---|---|---|---|
| Mar2025 | 14.23% | 33.99 | |
| Mar2024 | 10.62% | -3.54 | |
| Mar2023 | 11.01% | Positive | |
| Mar2022 | -23.44% | Negative | |
| Mar2021 | 5.56% | - | |
INDRAYANI BIOTECH Profit After Tax
[BOM: 526445]
| Y-o-Y | -27.15 % |
| 5 Yr CAGR | -90.58 % |
| Years | Profit After Tax | % Change | |
|---|---|---|---|
| Mar2025 | ₹6.37 Cr | -27.15 | |
| Mar2024 | ₹8.74 Cr | 96.78 | |
| Mar2023 | ₹4.44 Cr | Positive | |
| Mar2022 | ₹-11 Cr | Negative | |
| Mar2021 | ₹80,734 Cr | - | |
| PAT Margins | |
|---|---|
| Y-o-Y | Negative |
| 5 Yr CAGR | Negative |
| Years | PAT Margin(%) | % Change | |
|---|---|---|---|
| Mar2025 | -4.69 % | Negative | |
| Mar2024 | 6.27 % | -14.34 | |
| Mar2023 | 7.32 % | 1.53 | |
| Mar2022 | 7.21 % | Positive | |
| Mar2021 | -53.18 % | - | |
INDRAYANI BIOTECH Earnings Per Share (EPS)
[BOM: 526445]
| Y-o-Y | Negative |
| 5 Yr CAGR | Negative |
| Years | EPS | % Change | |
|---|---|---|---|
| Mar2025 | ₹-0.34 | Negative | |
| Mar2024 | ₹1.40 | -45.10 | |
| Mar2023 | ₹2.55 | 96.15 | |
| Mar2022 | ₹1.30 | Positive | |
| Mar2021 | ₹-3.25 | - | |
INDRAYANI BIOTECH Return on Capital Employed (ROCE)
[BOM: 526445]
| Y-o-Y | -77.85 % |
| 5 Yr CAGR | Positive |
| Years | ROCE | % Change | |
|---|---|---|---|
| Mar2025 | 3.19% | -77.85 | |
| Mar2024 | 14.4% | -35.86 | |
| Mar2023 | 22.45% | 37.06 | |
| Mar2022 | 16.38% | Positive | |
| Mar2021 | -23.16% | - | |
INDRAYANI BIOTECH Share Price vs Sensex
| Current Share Price | : | ₹14.6 |
| Current MarketCap | : | ₹ 66.2 Cr |
| Updated EOD on | : | Nov 21,2025 |
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| INDRAYANI BIOTECH | 3.1% |
-6% |
-64.6% |
| SENSEX | 0.8% |
1% |
9.9% |
INDRAYANI BIOTECH related INDICES
You may also like the below Video Courses
FAQ about INDRAYANI BIOTECH Financials
How the annual revenues of INDRAYANI BIOTECH have changed ?
The Revenues of INDRAYANI BIOTECH have increased by 2.02% YoY .
How the Earnings per Share (EPS) of INDRAYANI BIOTECH have changed?
The Earnings Per Share (EPS) of INDRAYANI BIOTECH has decreased by Negative YoY .
No other companies found in this Industry